Imipenem And Cilastatin Injection, Powder, For Solution
NDC Package 44567-705-10
Package Information
Imipenem And Cilastatin injection is imipenem and cilastatin for injection is contraindicated in patients who have shown hypersensitivity to any component of this product. This formulation utilizes a injection, powder, for solution delivery system. Marketed by Wg Critical Care, Llc, this product is identified by NDC 44567-705 and is authorized under FDA application ANDA207594.
Identification & Billing
- RxCUI: 1726214 - imipenem / cilastatin 500 MG Injection
- RxCUI: 1726214 - cilastatin 500 MG / imipenem 500 MG Injection
- RxCUI: 1726214 - cilastatin (as cilastatin sodium) 500 MG / imipenem 500 MG Injection
- RxCUI: 1726214 - imipenem 500 MG / cilastatin 500 MG Injection
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 44567 - Wg Critical Care, Llc
- 44567-705 - Imipenem And Cilastatin
- 44567-705-10 - 10 VIAL in 1 CARTON / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL
- 44567-705 - Imipenem And Cilastatin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Billing & HCPCS Mapping
To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.
Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 44567-705-10 identifies a specific commercial package of 10 vial in 1 carton / 1 injection, powder, for solution in 1 vial of Imipenem And Cilastatin, a human prescription drug labeled by Wg Critical Care, Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 10 billable units per package. This injection, powder, for solution is formulated for intravenous use and contains cilastatin sodium; imipenem anhydrous as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Wg Critical Care, Llc on March 09, 2021. The current certification is valid through December 31, 2026.
How is this Wg Critical Care, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 44567070510. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 10 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.
